Ayodele Adeigbola
Psychiatry · Yonkers, NYNPI 1407900053
Payments from drug & device makers
Across 146 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$324
- Otsuka America Pharmaceutical, Inc.$281
- Lundbeck LLC$215
- Bausch Health US, LLC$154
- Johnson & Johnson$73
- plus $436 from 12 others
What the payments were for
- Food & beverage$2,62898%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 74 | $1,192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $324 |
| Otsuka America Pharmaceutical, Inc. | 4 | $281 |
| Lundbeck LLC | 17 | $215 |
| Bausch Health US, LLC | 9 | $154 |
| Johnson & Johnson | 4 | $73 |
| Neos Therapeutics, LP | 3 | $66 |
| Idorsia Pharmaceuticals US Inc | 2 | $53 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $47 |
| Eisai Inc. | 3 | $46 |
| Sunovion Pharmaceuticals Inc. | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Adlon Therapeutics L.p. | 1 | $20 |
| Tris Pharma Inc | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$250
How this compares
$2,675 in reported general payments places this provider in the 85th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 18 | $282 |
| Lithium Carbonate | 12 | $238 |
| Clonazepam | 17 | $96 |
| Methylphenidate Hcl | 14 | $64 |
| Diazepam | 13 | $49 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Yonkers
- Yadagiri ChepuruYonkers$963K
- Elyssa BarronWhite Plains$12.8M
- Mark DibuonoStaten Island$11.9M
- Ronald BrennerHempstead$11.5M
- Anton PorsteinssonRochester$7.6M
- Michael LiebowitzNew York$7.1M
- Leslie CitromePomona$5.7M
- John KaneGlen Oaks$4M
- Inna Yuryev-GolgerBrooklyn$3M
- Subhdeep VirkBuffalo$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.